Page last updated: 2024-10-31

metyrapone and Granulocytic Leukemia, Chronic

metyrapone has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagel-Hiemke, M1
Hiemke, C1
Kummer, G1
Moritz, T1
Müller, H1
Seeber, S1
Niederle, N1

Other Studies

1 other study available for metyrapone and Granulocytic Leukemia, Chronic

ArticleYear
Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF alpha/IFN alpha therapy.
    Annals of hematology, 1992, Volume: 65, Issue:3

    Topics: Adrenocorticotropic Hormone; Antineoplastic Combined Chemotherapy Protocols; Body Temperature; Femal

1992